Healthcare provider profile · identity verified

Anton Grankin, M.D.

Family Practice · NORTH VERNON, IN · NPI 1942525027

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	516	146
Albuterol Sulfate Hfa	Albuterol Sulfate	375	119
Omeprazole	Omeprazole	331	80
Lisinopril	Lisinopril	282	83
Gabapentin	Gabapentin	272	66
Furosemide	Furosemide	251	67
Metformin Hcl	Metformin Hcl	235	64
Levothyroxine Sodium	Levothyroxine Sodium	211	47
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	204	34
Tamsulosin Hcl	Tamsulosin Hcl	188	54
Amlodipine Besylate	Amlodipine Besylate	164	52
Trazodone Hcl	Trazodone Hcl	158	47
Diclofenac Sodium	Diclofenac Sodium	157	52
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	152	46
Clonazepam	Clonazepam	138	22
Metoprolol Succinate	Metoprolol Succinate	125	41
Pantoprazole Sodium	Pantoprazole Sodium	121	35
Potassium Chloride	Potassium Chloride	120	34
Meloxicam	Meloxicam	115	35
Sertraline Hcl	Sertraline Hcl	113	26
Clopidogrel	Clopidogrel Bisulfate	100	28
Tramadol Hcl	Tramadol Hcl	99	33
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	97	24
Baclofen	Baclofen	93	32
Tizanidine Hcl	Tizanidine Hcl	91	30
Ozempic	Semaglutide	87	16
Alendronate Sodium	Alendronate Sodium	84	20
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	84	26
Ropinirole Hcl	Ropinirole Hcl	83	17
Mirtazapine	Mirtazapine	79	18
Escitalopram Oxalate	Escitalopram Oxalate	77	26
Fluticasone Propionate	Fluticasone Propionate	77	35
Simvastatin	Simvastatin	75	19
Hydrochlorothiazide	Hydrochlorothiazide	74	21
Losartan Potassium	Losartan Potassium	74	28
Duloxetine Hcl	Duloxetine Hcl	73	22
Ondansetron Odt	Ondansetron	72	30
Aripiprazole	Aripiprazole	69	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	69	18
Pravastatin Sodium	Pravastatin Sodium	69	18
Eliquis	Apixaban	67	15
Montelukast Sodium	Montelukast Sodium	67	18
Doxycycline Hyclate	Doxycycline Hyclate	60	58
Prednisone	Prednisone	60	50
Pregabalin	Pregabalin	60	12
Metoprolol Tartrate	Metoprolol Tartrate	59	21
Buspirone Hcl	Buspirone Hcl	56	12
Rosuvastatin Calcium	Rosuvastatin Calcium	55	18
Famotidine	Famotidine	54	12
Myrbetriq	Mirabegron	53	14
Alprazolam	Alprazolam	52	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	52	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	52	50
Jardiance	Empagliflozin	47	16
Sumatriptan Succinate	Sumatriptan Succinate	47	12
Hydroxyzine Hcl	Hydroxyzine Hcl	46	17
Mounjaro	Tirzepatide	46	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	45	suppressed
Ezetimibe	Ezetimibe	45	13
Fenofibrate	Fenofibrate	43	11
Spironolactone	Spironolactone	42	11
Symbicort	Budesonide/Formoterol Fumarate	42	11
Oxybutynin Chloride Er	Oxybutynin Chloride	41	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	40	suppressed
Bupropion Xl	Bupropion Hcl	39	suppressed
Glimepiride	Glimepiride	39	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	39	suppressed
Linzess	Linaclotide	39	suppressed
Topiramate	Topiramate	39	11
Triamcinolone Acetonide	Triamcinolone Acetonide	39	17
Carvedilol	Carvedilol	37	12
Meclizine Hcl	Meclizine Hcl	37	14
Citalopram Hbr	Citalopram Hydrobromide	36	11
Fluconazole	Fluconazole	36	20
Atenolol	Atenolol	35	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	34	31
Breo Ellipta	Fluticasone/Vilanterol	34	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	34	suppressed
Gemfibrozil	Gemfibrozil	33	suppressed
Nystatin	Nystatin	32	14
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	32	11
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	31	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	30	suppressed
Sucralfate	Sucralfate	30	suppressed
Allopurinol	Allopurinol	29	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	28	11
Donepezil Hcl	Donepezil Hcl	28	13
Ibuprofen	Ibuprofen	28	suppressed
Methylprednisolone	Methylprednisolone	28	25
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	28	suppressed
Januvia	Sitagliptin Phosphate	27	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	25	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	25	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	25	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	24	suppressed
Tradjenta	Linagliptin	24	suppressed
Clonidine Hcl	Clonidine Hcl	23	11
Glipizide	Glipizide	23	suppressed
Ventolin Hfa	Albuterol Sulfate	23	suppressed
Azithromycin	Azithromycin	22	21
Lorazepam	Lorazepam	21	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	suppressed
Glycopyrrolate	Glycopyrrolate	20	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	20	suppressed
Nitroglycerin	Nitroglycerin	20	11
Risperidone	Risperidone	20	suppressed
Xarelto	Rivaroxaban	19	suppressed
Estradiol	Estradiol	18	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	18	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	18	suppressed
Spiriva Respimat	Tiotropium Bromide	18	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Finasteride	Finasteride	17	suppressed
Levemir Flexpen	Insulin Detemir	16	suppressed
Methocarbamol	Methocarbamol	16	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	15	suppressed
Incruse Ellipta	Umeclidinium Bromide	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Midodrine Hcl	Midodrine Hcl	14	suppressed
Promethazine Hcl	Promethazine Hcl	14	suppressed
Celecoxib	Celecoxib	13	suppressed
Farxiga	Dapagliflozin Propanediol	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Cabergoline	Cabergoline	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Cephalexin	Cephalexin	11	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Varenicline Tartrate	Varenicline Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error